Tumor-to-blood ratios increased from day 2 to 4 p.i. in patients who underwent whole body PET scans (n = 4), which was considered to be suggestive for tumor-specific TGF-β-driven mAb uptake. This evidence concerns the gene TGFB1 and neoplasm.